Table 3.
Clinicopathological parameters of patients.
| Case id | Age | Gender | Tumor size(cm) | TNM | Histological type | Chemotherapy | Radiotherapy |
|---|---|---|---|---|---|---|---|
| 1 | 58 | Female | 1*1*1 | T3N1M0 | High-grade Serous IIIC | Paclitaxel; Lobaplatin |
NA |
| 2 | 53 | Female | 3*2.5*2.5 | T3N1M1 | High-grade Serous IVB | Taxol; Carboplatin | NA |
| 3 | 68 | Female | 5*3*2.2 | T3N1M0 | High-grade Serous IIIC | nab-paclitaxel, carboplatin | NA |
| 4 | 63 | Female | 15*13*13 | T3N1M0 | High-grade Serous IIIC | Lobaplatin | NA |
| 5 | 65 | Female | 16.5*11.5*2.5 | T3N1M0 | High-grade Serous IIIC | Cisplatin | NA |
| 6 | 45 | Female | 11.15*8.20*9.22 | T3N1M0 | High-grade Serous IIIC | Cisplatin | NA |
| 7 | 53 | Female | 11*9.5 | T3N1M1 | High-grade Serous IIIC | Taxol; Carboplatin | NA |
| 8 | 45 | Female | 8*5*1.2 | T3N0M0 | High-grade Serous IIIB | Taxol; Carboplatin | NA |
| 9 | 44 | Female | 4*4*3 | T3N1M1 | High-grade Serous IVA | Taxol; Carboplatin | NA |
NA, Not applicable.